Brind.

Neurocrine Biosciences and Grifols are both medical drugs stocks.

1 report, 1 independent Updated Aug 20

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Neurocrine Biosciences Grifols

Keep exploring

The entities involved

Neurocrine Biosciences
American biopharmaceutical company

Nothing else this week.
Grifols
Spanish pharmaceutical company
- Canadian Blood Services faces union calls for contract termination after Health Canada issued a non-compliance rating.Fri 17:53

Coverage

Newest first; wire copies grouped

Aug 20ZacksGRFS or NBIX: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Neurocrine Biosciences (NBIX). But which